Page last updated: 2024-08-21

butorphanol and Opioid-Related Disorders

butorphanol has been researched along with Opioid-Related Disorders in 25 studies

Research

Studies (25)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (16.00)	18.7374
1990's	13 (52.00)	18.2507
2000's	7 (28.00)	29.6817
2010's	1 (4.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balhara, YPS; Gupta, R; Sarkar, S; Shah, B	1
Jang, CG; Lee, KW; Lee, SY; Tian, YH; You, IJ	1
Fan, LW; Ho, IK; Ma, T; Rockhold, RW; Tanaka, S; Tien, LT	1
Fan, LW; Ho, IK; Ma, T; Park, Y; Rockhold, RW; Sasaki, K; Tanaka, S; Tien, LT	1
Chudapongse, N; Fan, LW; Ho, IK; Ma, T; Rockhold, RW; Sinchaisuk, S; Tanaka, S; Tien, LT	1
Chudapongse, N; Ho, IK; Kim, SY; Lee, SM; Levin, MC; Oh, JT; Park, HJ	1
Fan, LW; Ho, IK; Liu-Chen, LY; Park, Y; Rockhold, RW; Tanaka, S; Tien, LT	1
Feng, Y; Ho, IK; Tokuyama, S; Wakabayashi, H	2
Jasinski, DR; Preston, KL; Sullivan, JT; Testa, M	1
Ho, IK; Hoskins, B; Jaw, SP	1
Ho, IK; Hoskins, B; Tokuyama, S; Wakabayashi, H	1
Ho, IK; Tokuyama, S	1
Feng, YZ; Ho, IK; Hoshi, K; Rockhold, RW; Tokuyama, S	1
Ho, IK; Rockhold, RW; Zhu, H	1
Barta, PE; Bigelow, GE; Greenberg, BD; Lancaster, E; Pearlson, GD; Preston, KL; Schlaepfer, TE; Strain, EC	1
He, Z; Ho, IK; Tsang, BK; Wongchanapai, W	1
Ho, IK; Jang, CG; Rockhold, RW	1
Glatt, W	1
Ho, IK; Tokuyama, S; Yamamoto, T	1
Greenwald, MK; Stitzer, ML	1
Bigelow, GE; Liebson, IA; Preston, KL	2
Bickel, W; Bigelow, G; Liebson, I; Preston, K	1
Balster, RL; Lukas, SE	1

Reviews

3 review(s) available for butorphanol and Opioid-Related Disorders

Article	Year
Glutamate in opioid dependence. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 1997, Volume: 17, Issue:4 Topics: Analgesics, Opioid; Animals; Butorphanol; Glutamic Acid; Locus Coeruleus; Microdialysis; Opioid-Related Disorders; Rats; Receptors, Opioid, kappa; Substance Withdrawal Syndrome	1997
The role of glutamate in physical dependence on opioids. Japanese journal of pharmacology, 1998, Volume: 76, Issue:1 Topics: Analgesics, Opioid; Animals; Butorphanol; Disease Models, Animal; Glutamic Acid; Locus Coeruleus; Neurons, Afferent; Opioid-Related Disorders; Rats; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa; Substance Withdrawal Syndrome	1998
Review of self-administration. Drug and alcohol dependence, 1985, Volume: 14, Issue:3-4 Topics: Animals; Buprenorphine; Butorphanol; Cyclazocine; Humans; Macaca mulatta; Morphinans; Morphine; Nalbuphine; Opioid-Related Disorders; Papio; Pentazocine; Rats; Reinforcement, Psychology; Self Administration	1985

Trials

5 trial(s) available for butorphanol and Opioid-Related Disorders

Article	Year
Psychopharmacology and abuse potential of transnasal butorphanol. Drug and alcohol dependence, 1994, Volume: 35, Issue:2 Topics: Administration, Intranasal; Adult; Arousal; Butorphanol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Injections, Intramuscular; Male; Middle Aged; Opioid-Related Disorders; Pain Measurement	1994
Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects. The American journal of psychiatry, 1998, Volume: 155, Issue:4 Topics: Amygdala; Brain; Butorphanol; Cerebrovascular Circulation; Double-Blind Method; Emotions; Euphoria; Gyrus Cinguli; Humans; Hydromorphone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Placebos; Receptors, Opioid; Regional Blood Flow; Technetium Tc 99m Exametazime; Temporal Lobe; Thalamus; Tomography, Emission-Computed, Single-Photon	1998
A new method for detoxifying opioid-dependent patients. Journal of substance abuse treatment, 1999, Volume: 17, Issue:3 Topics: Administration, Intranasal; Adult; Aged; Analgesics, Opioid; Butorphanol; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome	1999
Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine. Drug and alcohol dependence, 1998, Dec-01, Volume: 53, Issue:1 Topics: Adult; Arousal; Brain; Butorphanol; Dose-Response Relationship, Drug; Double-Blind Method; Euphoria; Heroin Dependence; Humans; Hypnotics and Sedatives; Lorazepam; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome	1998
Butorphanol-precipitated withdrawal in opioid-dependent human volunteers. The Journal of pharmacology and experimental therapeutics, 1988, Volume: 246, Issue:2 Topics: Adult; Butorphanol; Cognition; Double-Blind Method; Humans; Hydromorphone; Injections, Intramuscular; Male; Methadone; Morphinans; Naloxone; Opioid-Related Disorders; Psychomotor Performance; Substance Withdrawal Syndrome	1988

Other Studies

17 other study(ies) available for butorphanol and Opioid-Related Disorders

Article	Year
Injection Butorphanol dependence: A case report. Asian journal of psychiatry, 2018, Volume: 35 Topics: Adult; Analgesics, Opioid; Buprenorphine; Butorphanol; GABA Modulators; Humans; Injections, Intravenous; Male; Naltrexone; Narcotic Antagonists; Nitrazepam; Opiate Substitution Treatment; Opioid-Related Disorders	2018
7-nitroindazole, nitric oxide synthase inhibitor, attenuates physical dependence on butorphanol in rat. Synapse (New York, N.Y.), 2008, Volume: 62, Issue:8 Topics: Analgesics, Opioid; Animals; Brain; Butorphanol; Cell Count; Disease Models, Animal; Enzyme Inhibitors; Indazoles; Male; Narcotic Antagonists; Neurons; Nitric Oxide; Nitric Oxide Synthase Type I; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	2008
Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain. Brain research bulletin, 2002, Volume: 58, Issue:2 Topics: Analgesics, Opioid; Animals; Binding Sites; Binding, Competitive; Brain; Butorphanol; Male; Morphine; Naloxone; Narcotic Antagonists; Neurons; Opioid-Related Disorders; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Up-Regulation	2002
Butorphanol dependence and withdrawal decrease hippocampal kappa 2-opioid receptor binding. Brain research, 2002, Dec-27, Volume: 958, Issue:2 Topics: Animals; Butorphanol; Hippocampus; Male; Opioid-Related Disorders; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome	2002
Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol. Neuroscience, 2003, Volume: 121, Issue:4 Topics: Animals; Behavior, Animal; Brain; Butorphanol; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Up-Regulation	2003
Proteomic analysis of phosphotyrosyl proteins in the rat brain: effect of butorphanol dependence. Journal of neuroscience research, 2004, Sep-15, Volume: 77, Issue:6 Topics: Animals; Brain; Butorphanol; Male; Opioid-Related Disorders; Phosphorylation; Phosphotyrosine; Proteins; Proteomics; Rats; Rats, Sprague-Dawley	2004
Butorphanol dependence increases hippocampal kappa-opioid receptor gene expression. Journal of neuroscience research, 2005, Oct-15, Volume: 82, Issue:2 Topics: Animals; Brain; Butorphanol; Disease Models, Animal; Down-Regulation; Gene Expression; Hippocampus; Injections, Intraventricular; Male; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; RNA, Messenger; Substance Withdrawal Syndrome; Up-Regulation	2005
Ca2+ channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats. European journal of pharmacology, 1995, Jun-06, Volume: 279, Issue:1 Topics: Animals; Butorphanol; Calcium Channel Blockers; Diltiazem; Male; Medulla Oblongata; Morphine Dependence; Naloxone; Opioid-Related Disorders; Pons; Protein Kinase C; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	1995
Opioid antagonists and butorphanol dependence. Pharmacology, biochemistry, and behavior, 1993, Volume: 44, Issue:3 Topics: Animals; Behavior, Animal; Butorphanol; Indoles; Injections, Intraventricular; Male; Morphinans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Substance Withdrawal Syndrome	1993
Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8. European journal of pharmacology, 1995, Sep-15, Volume: 284, Issue:1-2 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Behavior, Animal; Butorphanol; Cytosol; Enzyme Inhibitors; Isoquinolines; Male; Medulla Oblongata; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Piperazines; Pons; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	1995
Naloxone-precipitated changes in biogenic amines and their metabolites in various brain regions of butorphanol-dependent rats. Pharmacology, biochemistry, and behavior, 1996, Volume: 54, Issue:2 Topics: Animals; Biogenic Amines; Biogenic Monoamines; Brain Chemistry; Butorphanol; Injections, Intraperitoneal; Male; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	1996
Inhibitory effects of diltiazem, an L-type Ca2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats. Brain research, 1996, May-25, Volume: 722, Issue:1-2 Topics: Animals; Butorphanol; Calcium Channel Blockers; Diltiazem; Glutamic Acid; Locus Coeruleus; Male; Microdialysis; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	1996
Relative involvement of spinal opioid receptors in physical dependence on intrathecal butorphanol and morphine. Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:4 Topics: Animals; Butorphanol; Injections, Spinal; Male; Morphine; Morphine Dependence; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Spinal Cord; Substance Withdrawal Syndrome	1998
Withdrawal from butorphanol dependence alters binding of [3H]phorbol dibutyrate to protein kinase C, but not of [3H]forskolin to adenylate cyclase. Brain research, 1999, Mar-13, Volume: 821, Issue:2 Topics: Adenylyl Cyclases; Animals; Autoradiography; Brain; Brain Chemistry; Butorphanol; Carcinogens; Colforsin; Male; Narcotic Antagonists; Opioid-Related Disorders; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Tritium	1999
A protein kinase inhibitor, H-7, blocks naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats. Brain research bulletin, 2000, Jul-15, Volume: 52, Issue:5 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain; Butorphanol; Cerebral Cortex; Corpus Striatum; Dopamine; Enzyme Inhibitors; Homovanillic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Limbic System; Male; Mesencephalon; Morphine; Naloxone; Opioid-Related Disorders; Protein Kinase Inhibitors; Protein Kinases; Rats; Rats, Sprague-Dawley	2000
Butorphanol-precipitated withdrawal in opioid-dependent human volunteers. NIDA research monograph, 1987, Volume: 76 Topics: Butorphanol; Heart Rate; Humans; Hydromorphone; Male; Methadone; Morphinans; Naloxone; Opioid-Related Disorders; Pupil; Respiration; Skin Temperature; Substance Withdrawal Syndrome; Surveys and Questionnaires	1987
Drug discrimination in human post-addicts: agonist/antagonist opioids. NIDA research monograph, 1988, Volume: 81 Topics: Buprenorphine; Butorphanol; Discrimination Learning; Dose-Response Relationship, Drug; Humans; Hydromorphone; Male; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Pentazocine	1988